zeb wins AWS Rising Star Partner of the Year – Consulting Award
RxGenomix is a healthcare technology company focused on delivering personalized pharmacogenomic insights to improve medication outcomes. With growing patient volumes and the complexity of genomic data, their clinical teams needed a more scalable, efficient way to produce patient-specific Medical Action Plans (MAPs). The customer partnered with zeb, an AWS Advanced Tier Consulting Partner, to build an AI-powered solution using Amazon Bedrock and Claude 3.7 Sonnet, automating the MAP generation process while improving accuracy, security, and scalability.
95%
Reduction in manual effort per report
93–95%
Accuracy in gene-drug interaction extraction
150%
Increase in daily report processing capacity
Industry
Healthcare
Service
Healthcare Data Processing Pipelines with Bedrock (Claude 3.7 Sonnet)
Tech Stack
Amazon ECS with AWS Fargate, Amazon ECR, ALB (Application load balancer), Amazon SNS, Amazon SQS, AWS Lambda, Amazon EventBridge, Amazon RDS, AWS Secrets Manager, Amazon API Gateway, Amazon S3, AWS Certificate Manager, AWS VPN, Amazon CloudWatch, Databricks, Snowflake
RxGenomix clinicians were spending significant time, often several hours, manually reviewing and summarizing 40–60 page genomic and medical reports to create provider-ready Medical Action Plans (MAPs). This labor-intensive workflow posed several critical challenges:
Continue Reading
To improve operational efficiency and reduce manual effort, the customer needed an automated, secure, and accurate solution that could integrate with existing clinical workflows and meet compliance standards.
Our customer set out to transform their Medical Action Plan (MAP) generation process with the following goals:
To meet the outlined objectives, zeb experts designed a robust solution using AWS-native services and AI models from Amazon Bedrock.
Served as the foundational storage for all incoming genomic reports, including XML files and scanned PDFs. Data was securely stored in encrypted buckets with fine-grained IAM-based access controls.
To manage and orchestrate the summarization workflow, RxGenomix utilized Amazon ECS with Fargate. Containerized microservices handled tasks such as ingesting reports from S3, formatting medication and gene interaction data, invoking Claude 3.5 Sonnet via Amazon Bedrock, and generating structured action plans. Fargate provided a fully managed, serverless compute environment for containers, allowing RxGenomix to scale on demand while avoiding the operational complexity of managing servers or provisioning infrastructure manually.
Powered the core summarization engine that interprets large, complex pharmacogenomic reports and converts them into actionable MAPs suitable for provider use.
Managed all API credentials and secure endpoints. This eliminated the need for hardcoded secrets and ensured centralized, auditable access to sensitive data and services.
To support model iteration and controlled feature releases, CodeCommit and CodePipeline were used to manage application and prompt templates. Each model version passed through a structured approval flow, enabling audit-ready updates in a healthcare environment.
MAPs included a built-in feedback mechanism, allowing providers to annotate drafts with suggestions or corrections. These annotations were collected via Lambda APIs and persisted in S3 as structured feedback files, enabling future model fine-tuning and personalization.
Timeline
The project was completed within 3 months through phased iterations, starting with foundational infrastructure and progressively incorporating AI-based summarization and feedback capabilities. Early integration of provider feedback enabled rapid adoption and continuous refinement, leading to measurable impact in a short span of time.
Operational KPIs
Clinical & Adoption Outcomes
Business Impact
Our customer’s journey to automate Medical Action Plan generation with zeb’s AWS-based solution led to a complete transformation in their clinical operations. By integrating Amazon Bedrock with Claude 3.7 Sonnet into a secure, ECS pipeline, they reduced manual effort by 95% and tripled their daily processing capacity. The new system delivered accurate, compliant, and provider-ready summaries, empowering clinicians to focus more on patient care. This AI-powered automation positioned RxGenomix to scale personalized pharmacogenomic services while maintaining clinical oversight and trust, setting a new benchmark for care delivery efficiency.